A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis-Reference-Cited by-同舟云学术

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

Published:2017-03-03 Issue:4 Volume:69 Page:837-845
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Langford Carol A.¹,Cuthbertson David²,Ytterberg Steven R.³,Khalidi Nader⁴,Monach Paul A.⁵,Carette Simon⁶,Seo Philip⁷,Moreland Larry W.⁸,Weisman Michael⁹,Koening Curry L.¹⁰,Sreih Antoine G.¹¹,Spiera Robert¹²,McAlear Carol A.¹¹,Warrington Kenneth J.³,Pagnoux Christian⁶,McKinnon Kathleen⁸,Forbess Lindsy J.⁹,Hoffman Gary S.¹,Borchin Renée²,Krischer Jeffrey P.²,Merkel Peter A.¹¹,Hajj‐Ali Rula,Tuthill Katherine,Gartner Kathleen,Madden Leah,Matteson Eric L.,Kermani Tanaz,Jaquith Jane,Amudala Naomi,Clark‐Cotton Manuella,Messier Sandra,Farquharson Julia,Jagadeesh Samyukta,McBride Dawn,Venuturupalli Swamy,Wallace Daniel,Phan Richard,Verde Nadia,Salinas Denise,Godina Jennifer,Davids Morgana,Udeh Uzunma,Sejismundo Lourdes,Harris Jennifer,

Affiliation:

1. Cleveland ClinicCleveland Ohio

2. University of South FloridaTampa

3. Mayo ClinicRochester Minnesota

4. St. Joseph's Hospital, McMaster UniversityHamilton Ontario Canada

5. Boston UniversityBoston Massachusetts

6. Mount Sinai HospitalToronto Ontario Canada

7. Johns Hopkins UniversityBaltimore Maryland

8. University of PittsburghPittsburgh Pennsylvania

9. Cedars–Sinai Medical CenterLos Angeles California

10. University of UtahSalt Lake City

11. University of PennsylvaniaPhiladelphia